[HTML][HTML] Current FDA-approved therapies for high-grade malignant gliomas

JP Fisher, DC Adamson - Biomedicines, 2021 - mdpi.com
The standard of care (SOC) for high-grade gliomas (HGG) is maximally safe surgical
resection, followed by concurrent radiation therapy (RT) and temozolomide (TMZ) for 6 …

Standards of care for treatment of recurrent glioblastoma—are we there yet?

M Weller, T Cloughesy, JR Perry, W Wick - Neuro-oncology, 2013 - academic.oup.com
Newly diagnosed glioblastoma is now commonly treated with surgery, if feasible, or biopsy,
followed by radiation plus concomitant and adjuvant temozolomide. The treatment of …

Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries

M Kuljanin, DC Mitchell, DK Schweppe… - Nature …, 2021 - nature.com
Current methods used for measuring amino acid side-chain reactivity lack the throughput
needed to screen large chemical libraries for interactions across the proteome. Here we …

[HTML][HTML] DNA methylation biomarkers: cancer and beyond

T Mikeska, JM Craig - Genes, 2014 - mdpi.com
Biomarkers are naturally-occurring characteristics by which a particular pathological process
or disease can be identified or monitored. They can reflect past environmental exposures …

Randomized phase II trial of vincristine-irinotecan with or without temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: A European …

AS Defachelles, E Bogart, M Casanova… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE The VIT-0910 trial was conducted to evaluate efficacy and safety of the
vincristine-irinotecan combination with and without temozolomide (VIT and VI, respectively) …

Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM

MS Petronek, V Monga, KL Bodeker, M Kwofie… - Clinical cancer …, 2024 - AACR
Abstract Purpose: Pharmacologic ascorbate (P-AscH−) is hypothesized to be an iron (Fe)-
dependent tumor-specific adjuvant to chemoradiation in treating glioblastoma (GBM). This …

Epigenetic modifications in prostate cancer

M Sugiura, H Sato, M Kanesaka… - … Journal of Urology, 2021 - Wiley Online Library
Prostate cancer is a major cause of cancer‐related deaths among men worldwide. In
addition to genomic alterations, epigenetic alterations accumulated in prostate cancer have …

SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

J Hadoux, J Favier, JY Scoazec… - … Journal of Cancer, 2014 - Wiley Online Library
Cyclophosphamide–dacarbazine–vincristine regimen is recommended for the treatment of
malignant pheochromocytoma and paraganglioma (MPP); however, dacarbazine is the only …

Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools

AE Pegg - Chemical research in toxicology, 2011 - ACS Publications
O 6-Alkylguanine-DNA alkyltransferase (AGT) is a widely distributed, unique DNA repair
protein that acts as a single agent to directly remove alkyl groups located on the O 6-position …

Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma

Y Zhou, X Zhang, A Klibanski - Molecular and cellular endocrinology, 2014 - Elsevier
Human pituitary adenomas are the most common intracranial neoplasms. Approximately 5%
of them are familial adenomas. Patients with familial tumors carry germline mutations in …